Momenta Pharmaceuticals Announces Date of Second Quarter 2014 Financial Results Conference Call and Webcast
July 15 2014 - 4:05PM
Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology
company specializing in the characterization and engineering of
complex drugs, will release its financial results for the second
quarter ended June 30, 2014 before the U.S. financial markets open
on Thursday, July 31, 2014.
Management will host a conference call on that date at 10:00
a.m. EDT to discuss these results and provide an update on the
company. To access the call, please dial (877) 224-9084 (domestic)
or (720) 545-0022 (international) prior to the scheduled conference
call time and provide the access code 71494254. A live webcast of
the call will be available on the "Investors" section of the
company's website, www.momentapharma.com. Please go to the site at
least 15 minutes prior to the call in order to register, download,
and install any necessary software. An archived version of the
webcast will be posted on the Momenta website approximately two
hours after the call.
About Momenta
Momenta Pharmaceuticals is a biotechnology company specializing
in the detailed structural analysis of complex mixture drugs and is
headquartered in Cambridge, MA. Momenta is applying its technology
to the development of generic versions of complex drugs, biosimilar
and potentially interchangeable biologics, and to the discovery and
development of novel drugs.
To receive additional information about Momenta, please visit
the website at www.momentapharma.com, which does not form a part of
this press release. The company's logo, trademarks, and service
marks are the property of Momenta Pharmaceuticals, Inc. All other
trade names, trademarks, or service marks are property of their
respective owners.
CONTACT: Momenta Pharmaceuticals, Inc.
ir@momentapharma.com
Momenta Pharmaceuticals (NASDAQ:MNTA)
Historical Stock Chart
From Aug 2024 to Sep 2024
Momenta Pharmaceuticals (NASDAQ:MNTA)
Historical Stock Chart
From Sep 2023 to Sep 2024